Chemesis International Inc. Announces Brand Partnership with Ubican Global
Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program VANCOUVER, BC / ACCESSWIRE...
News
Sunshine Biopharma Pays Off Convertible Notes in Cash Preventing New Shares From Hitting the Market
MONTREAL, QC / ACCESSWIRE / December 3, 2020 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the...
DX Medical Solutions to Launch “COV-iD” in Europe’s Biggest Airports to Provide Tested Travel
LONDON, UK / ACCESSWIRE / December 3, 2020 / With the pandemic going on an almost one year stretch of...
National and State Medicaid Leaders Join Revel + NovuHealth Medicaid Advisory Council
New Council consists of diverse group of experts who created the vision, design and support systems of federal and state...
Intrivo Diagnostics Inks National Distribution Agreements with Concordance Healthcare Solutions and NDC for Access Bio CareStart™ COVID-19 Tests
Major supply chain agreements will ensure broad access to rapid testing solutions for patients and healthcare providers across US LOS...
MedArrive launches to bring more humanity to healthcare
With $4.5 million in funding from Kleiner Perkins and Define Ventures, and backed by Redesign Health, MedArrive is poised to...
Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio
New Random Integration Transgenic Animal Model Generation Solution AvailableRENSSELAER, New York, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a...
Parexel Named Best Contract Research Organization by Scrip
Company recognized for innovative and effective use of real-world data and flexible trial designsBOSTON and DURHAM, N.C., Dec. 03, 2020...
AXIM® Biotechnologies Develops ELISA-Based Neutralizing Antibody Diagnostic Test for COVID-19 and Applies for Patent; Company’s Fourth COVID-19 Test-Focused Patent Application
SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or the “Company”), an international...
Allied Corp. Strengthens National Brand Support with the Signing of Elite Athlete David Lipson
KELOWNA, British Columbia, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the "Company") (OTCQB: ALID), an international medical...
OrthoPediatrics Named 2020 Corporate Champion of the Year By World Pediatric Project
WARSAW, Ind., Dec. 03, 2020 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a Company focused exclusively on...
Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual Congress
Phase 2 expansion cohort data supports ongoing Phase 3 trialMARSEILLE, France, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA...
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
Combination Offers Customers Access to Largest U.S. Oncology Real World Data Source and Best-in-Class Product Development Expertise for Faster, Smarter...
BioAge Raises $90M to Treat Aging and Age-related Diseases
Proceeds will support advancement of the company’s pipeline and proprietary platform for identifying and developing therapies to treat diseases of...
Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
WATERTOWN, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics...
Innate Pharma to present additional efficacy data for monalizumab in combination with cetuximab in head and neck cancer at the ESMO immuno-oncology virtual congress
Phase 2 expansion cohort data supports ongoing Phase 3 trialMarseille, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext...
Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
Nes Ziona, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company,...
FDA Clears Rezolute’s IND Application for RZ402
RZ402 is an orally available plasma kallikrein inhibitor in development for the treatment of diabetic macular edemaREDWOOD CITY, Calif., Dec....
PolyPid to Host Key Opinion Leader Call Discussing D-PLEX₁₀₀ and the Prevention of Surgical Site Infections
PETAH TIKVA, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted,...
Research From Exergen Corporation Shows Morning-Only Temperature Readings May Miss up to Half of All Fevers
Twice Daily Temperature Taking Taking your temperature twice daily is the most accurate way to screen for fever, a leading...